Dr. Bazhenova is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3855 Health Sciences Drive, MC 0987
La Jolla, CA 92037Phone+1 858-822-6189Fax+1 858-822-6190- Is this information wrong?
Summary
- I am a Clinical Professor of Medicine at UC San Diego Moores Cancer Center, Lung Cancer Unit Leader and a Director of the Hematology Oncology training program. My clinical practice and research concentrate on lung cancer. I have vast experience in clinical trial management, design and implementation. I serve as Chair of UC San Diego Protocol Review and Monitoring committee. I an a member of Alliance Respiratory Committee. I am a recipient of NCI Clinical Trial Leadership Award, San Diego Best Doctors awards and Women Who Mean Business Award. My main research interest is drug development.
I completed my M.D. at Nizhny Novgorod State Medical Academy in Nizhny Novgorod, Russia. I graduated from Internal medicine residency at University of California Los Angeles/ West Los Angeles VA medical center and then completed a fellowship in Hematology-Oncology at Scripps-Green Hospital in La Jolla in 2005 and have been in practice at NCI designated UC San Diego Moores Cancer Center since 2005.
Education & Training
- Scripps Clinic/Scripps Green HospitalFellowship, Hematology and Medical Oncology, 2002 - 2005
- UCLA-VA Greater Los AngelesResidency, Internal Medicine, 1999 - 2002
- Nizhny Novgorod State Medical Academy Class of 1994
Certifications & Licensure
- CA State Medical License 2001 - 2025
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
- Super Doctor SuperDoctors.com
Clinical Trials
- Study Evaluating the Addition of Fulvestrant to Erlotinib in Stage IIIB/IV Non-Small Cell Lung Cancer Start of enrollment: 2007 Sep 01
- Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer Start of enrollment: 2011 May 01
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-Tumor Activity of the Oral Anaplastic Lymphoma Kinase (ALK)/Epidermal Growth Factor Receptor (EGFR) Inhibitor Brigatinib (AP26113) Start of enrollment: 2011 Sep 20
- Join now to see all
Publications & Presentations
PubMed
- Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2023.3.Owen, D. H., Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, Krishna Alluri, Narjust Florez, Shirish Gadgeel, Gregory Masters, Erin L Schenk, Bryan J Schneider...> ;Journal of Clinical Oncology. 2024 Apr 10
- Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.3.Owen, D. H., Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, Krishna Alluri, Narjust Florez, Shirish Gadgeel, Gregory Masters, Erin L Schenk, Bryan J Schneider...> ;Journal of Clinical Oncology. 2024 Apr 10
- Multi-omics analysis reveals immune features associated with immunotherapy benefit in squamous cell lung cancer patients from Phase III Lung-MAP S1400I trial.Parra, E., Zhang, J., Duose, D., Gonzalez-Kozlova, E., Redman, M., Chen, H., Manyam, G., Kumar, G., Zhang, J., Song, X., Lazcano, R., Marques-Piubelli, M., Laberiano-F...> ;Clinical Cancer Research. 2024 Jan 26
- Join now to see all
Authored Content
- Efficacy of Selpercatinib in RET Fusion–Positive Non–Small-Cell Lung CancerAugust 2020
- Efficacy of Selpercatinib in RET Fusion–Positive Non–Small-Cell Lung CancerAugust 2020
- Efficacy of Selpercatinib in RET Fusion–Positive Non–Small-Cell Lung CancerAugust 2020
Press Mentions
- Cancer Status Report: Overall Death Rate Continues to DropJanuary 15th, 2022
- Lung-MAP: A Five-Year Recap on the First Master Protocol Trial in Cancer ResearchFebruary 21st, 2020
- Breathing in Life with Stage IV Lung CancerNovember 26th, 2019
- Join now to see all
Professional Memberships
- Member
- IASLCMember
- AACRMember
- ESMOMember
Hospital Affiliations
- UC San Diego Medical Center - HillcrestSan Diego, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: